SecSonar.com

Avantor, Inc. (AVTR)

Avantor, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Avantor, Inc. (AVTR) is a Medical - Instruments & Supplies company based in US with a market capitalization of $6.4B. Revenue declined 3.4% year-over-year and the company generated $495M in free cash flow. This page tracks AVTR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 13.5K employees · IPO May 17, 2019

Valuation

Valuation & price

$7.62 · as of May 17, 2026 · -51.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.15

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$15.60$11.50$7.41Jul 25Dec 25Jul 26Jul 7, 25$13.51Jul 9, 25$13.57Jul 11, 25$13.58Jul 15, 25$12.82Jul 17, 25$13.29Jul 21, 25$12.34Jul 23, 25$13.60Jul 25, 25$14.21Jul 29, 25$14.01Jul 31, 25$13.44Aug 4, 25$11.30Aug 6, 25$11.18Aug 11, 25$12.10Aug 13, 25$13.07Aug 15, 25$12.93Aug 19, 25$12.98Aug 21, 25$12.56Aug 25, 25$13.21Aug 27, 25$13.19Aug 29, 25$13.47Sep 3, 25$12.82Sep 5, 25$13.31Sep 9, 25$12.83Sep 11, 25$13.01Sep 16, 25$12.71Sep 18, 25$12.86Sep 22, 25$12.45Sep 24, 25$12.01Sep 26, 25$11.84Sep 30, 25$12.48Oct 2, 25$13.77Oct 6, 25$14.09Oct 8, 25$13.75Oct 10, 25$13.40Oct 14, 25$13.91Oct 16, 25$14.57Oct 21, 25$15.60Oct 23, 25$15.46Oct 27, 25$15.11Oct 29, 25$11.58Oct 31, 25$11.82Nov 4, 25$11.58Nov 6, 25$11.32Nov 10, 25$11.50Nov 12, 25$11.55Nov 14, 25$11.38Nov 18, 25$11.14Nov 20, 25$10.99Nov 25, 25$11.85Nov 28, 25$11.73Dec 2, 25$11.64Dec 4, 25$11.15Dec 8, 25$10.71Dec 10, 25$11.51Dec 12, 25$11.17Dec 16, 25$11.20Dec 18, 25$11.07Dec 22, 25$11.24Dec 24, 25$11.28Dec 29, 25$11.38Jan 2, 26$11.46Jan 6, 26$12.27Jan 8, 26$12.06Jan 12, 26$12.28Jan 14, 26$12.38Jan 16, 26$12.16Jan 21, 26$12.21Jan 23, 26$11.80Jan 27, 26$11.65Jan 29, 26$10.81Feb 2, 26$11.07Feb 4, 26$11.14Feb 9, 26$11.23Feb 11, 26$9.64Feb 13, 26$9.20Feb 18, 26$9.27Feb 20, 26$9.03Feb 24, 26$9.11Feb 26, 26$9.01Mar 2, 26$8.81Mar 4, 26$8.65Mar 6, 26$8.17Mar 10, 26$8.15Mar 12, 26$7.90Mar 17, 26$7.80Mar 19, 26$7.61Mar 23, 26$7.59Mar 25, 26$7.69Mar 27, 26$7.41Mar 31, 26$7.84Apr 2, 26$7.90Apr 7, 26$8.00Apr 9, 26$7.92Apr 13, 26$8.18Apr 15, 26$8.37Apr 17, 26$8.52Apr 22, 26$8.28Apr 24, 26$7.90Apr 28, 26$7.86Apr 30, 26$8.10May 4, 26$7.99May 6, 26$8.43May 8, 26$8.31May 12, 26$8.17May 14, 26$7.94May 18, 26$7.60May 20, 26$7.88May 22, 26$8.12May 28, 26$9.15Jun 1, 26$9.19Jun 3, 26$9.07Jun 5, 26$9.16Jun 9, 26$9.91Jun 11, 26$9.66Jun 15, 26$9.71Jun 17, 26$9.46Jun 22, 26$9.35Jun 24, 26$9.69Jun 26, 26$10.28Jul 2, 26$10.13
$7.4152-week range$15.60
Loading valuation history…

Fundamentals

Key fundamentals

$6.4B

Market cap

-3.4%

Revenue growth (YoY)

32.6%

Gross margin

$495M

Free cash flow (USD)

$3.6B

Net debt

-0.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$691.3MFY 2017$1.2BFY 2018$5.9BFY 2019$6.0BFY 2020$6.4BFY 2021$7.4BFY 2022$7.5BFY 2023$7.0BFY 2024$6.8BFY 2025$6.6B
$691.3M$6.6B

Free cash flow by year

2016 → 2025

FY 2016$43.0MFY 2017$-192.7MFY 2018$162.8MFY 2019$302.4MFY 2020$868.2MFY 2021$842.5MFY 2022$710.2MFY 2023$723.6MFY 2024$692.0MFY 2025$495.0M
$43M$495M

Gross margin by year

2021 → 2025

FY 202133.9%FY 202234.6%FY 202333.9%FY 202433.6%FY 202532.6%
33.9%32.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

2

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 29, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 12, 2026Filing
  • Insider buyInsider Buy $83KLUCIER GREGORY T · Director · $83.2KMay 11, 2026Filing
  • Insider buyInsider Buy $204KDingemans Simon · Director · $203.5KMay 5, 2026Filing
  • 8-K eventEarnings ReleaseApr 29, 2026Filing
  • Quarterly report10-Q FiledApr 29, 2026Filing
  • 8-K eventExecutive AppointmentApr 23, 2026Filing
  • 8-K eventCFO ResignationApr 1, 2026Filing

Questions

Frequently asked questions

What is Avantor, Inc.'s market cap?

Avantor, Inc. (AVTR) has a market capitalization of $6.4B.

What is AVTR's P/E ratio?

A meaningful P/E ratio is not available for AVTR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is AVTR's price-to-book (P/B) ratio?

AVTR trades at 1.15 times book value per share.

Are insiders buying AVTR stock?

Yes — SEC Form 4 filings show 2 open-market insider buys and 0 sells at Avantor, Inc. in the last 90 days.

Same arena

Related companies in Medical - Instruments & Supplies

TFX

Teleflex Incorporated

$5.7B

RGEN

Repligen Corporation

$7.1B

ATR

AptarGroup, Inc.

$7.4B

STVN

Stevanato Group S.p.A.

$5.2B

MMSI

Merit Medical Systems, Inc.

$3.8B

ICUI

ICU Medical, Inc.

$3.4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.